Skip to content

Journal of psychopharmacology (Oxford, England)

ISSN 1461-7285

159 papers in the library · 2,975 citations · publishing 1992-2026

Papers

Sort Most recent Most cited

The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.

Journal of psychopharmacology (Oxford, England) March 2006 Joanna K Huxster, Alessandro Pirona, Michael J Morgan

All previous studies of the sub-acute effects of ecstasy have failed to adequately control for group differences in psychopathology and past and concurrent substance use. The present study was designed to avoid these limitations. At an initial pre-drug baseline, a sample of 38 regular ecstasy users provided full substance histories and completed measures of personality and self-reported...

Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.

Journal of psychopharmacology (Oxford, England) March 2006 Eleanor J Bull, Veronica Porkess, Michael Rigby et al.

The current study examined the long-term effect of brief exposure to 3,4-methylenedioxymethamphetamine (MDMA) on local cerebral glucose utilization (LCGU) in specific brain regions immediately following administration of the 5-HT2A/2C receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Wistar rats (post-natal day (PND) 28, n = 24) were administered MDMA (5 mg/kg, i.p.) or...

New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').

Journal of psychopharmacology (Oxford, England) November 1, 2005 Fabrizio Schifano, Paolo Deluca, Lisa Agosti et al. 70 citations

2C-T-7 ('Blue Mystic'), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first...

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.

Journal of psychopharmacology (Oxford, England) January 2005 Harry Sumnall, Jon C. Cole

National drugs information strategies convey the message that use of Ecstasy is associated with an increase in both the incidence and severity of major depressive disorder. However, very little primary research supports this. Unlike apparent deficits in higher cognitive functions, most published studies have found no difference in self-reported depressive symptomatology between Ecstasy users...

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

Journal of psychopharmacology (Oxford, England) March 1, 2003 Z Abdul-Monim, G P Reynolds, J C Neill

The glutamate/N-methyl-D-aspartate receptor antagonist phencyclidine (PCP) has been shown to induce both positive and negative symptoms of schizophrenia, as well as cognitive deficits, thus providing a relatively valid model of psychosis. Isolation rearing from weaning in the rat has been proposed as a non-pharmacological model of psychosis. The aim of the present study was to explore the...

Hypnopompic hallucinations with donepezil.

Journal of psychopharmacology (Oxford, England) 2000 G A Yorston, R Gray

A case of hypnopompic hallucinations associated with donepezil is described. Electroencephalogram (EEG) and sleep EEG changes are common in Alzheimers Disease and acetylcholinesterase inhibitor drugs can affect rapid eye movement sleep and alertness. The importance of assessing sleep in patients treated with these drugs is discussed.

The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers.

Journal of psychopharmacology (Oxford, England) January 1996 G C Harborne, F L Watson, D T Healy et al.

The cognitive and subjective effects of sub-anaesthetic doses of ketamine on healthy volunteers were examined. Twelve healthy volunteers received 25 mg ketamine, 10 mg ketamine and saline placebo, i.m. in a double-blind, Latin square design. A cognitive, perceptual and self-report test battery was administered over 45 min. The order of tests was rotated to control for timing effects. Ketamine...

Chemical dissociation of human awareness: focus on non-competitive NMDA receptor antagonists.

Journal of psychopharmacology (Oxford, England) January 1992 E F Domino

Since the mid-1950s the pharmaceutical industry has developed a number of chemicals, including phencyclidine, ketamine and related arylcyclohexylamines (PCE and TCP), dizocilpine (MK-801), N-allylnormetazocine [ NANM, (±)SKF-10,047], etoxadrol, dioxadrol and its enantiomers dexoxadrol and levoxadrol, which produce a constellation of unusual behavioral effects in animals and man. The compounds...

Altered consciousness: pharmacology and phenomenology BAP Summer Meeting, York, July 1991: Sleep and general anaesthesia as altered states of consciousness.

Journal of psychopharmacology (Oxford, England) January 1992 R Munglani, J G Jones

In this article parallels are drawn between sleep and anaesthesia. Both can be described as 'behavioural states' in which stimulation and inhibition of certain neuronal groups will give rise to specific psychological states. The neuronal mechanisms leading to these states are reviewed and compared. Sensory information flow through the thalamus is reduced in sleep and anaesthesia, the thalamic...